Nonmetastatic pelvic Ewing sarcoma: Report of the French Society of Pediatric Oncology

Medical and Pediatric Oncology

Volumn 33, Issue 5, 1999, Pages 444-449

  Carrie, Christian ^a   Mascard, Eric ^b   Gomez, Frederic ^a   Habrand, Jean Louis ^c   Alapetite, Claire ^d   Oberlin, Odile ^c   Moncho, Valerie ^e   Hoffstetter, Sylvette ^f  

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d INSTITUT CURIE   (France)

^e CENTRE OSCAR LAMBRET   (France)

^f CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Ewing sarcoma; Pelvic bone; Radiotherapy; Surgery

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; EWING SARCOMA; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PELVIC BONES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL ANALYSIS;

EID: 0032706020     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199911)33:5<444::AID-MPO2>3.0.CO;2-D     Document Type: Article

References (17)

1. Ewing J. Diffuse endothelioma of bone. Proc NY Pathol Soc 1921;21:17-24.
2. Oberlin O, Patte C, Demeocq F, et al. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Eur J Cancer 1985;21:463-467.
3. Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 Trial. Int J Radiat Oncol Biol Phys 1995;32:919-930.
4. Marcus RB, Springfield DS, Graham-Pole JR, et al. Late follow up of a short term intensive regimen for Ewing's sarcoma. Am J Clin Oncol 1991;14:446-450.
5. Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, non metastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup Study. J Clin Oncol 1990;8:1664-1674.
6. Evans RG. The four S's of Ewing's sarcoma. Int J Radiat Oncol Biol Phys 1991;21:1671-1673.
7. Kaplan ES, Meier P. Nonparametric estimations from incomplete observations. Am Statist Assoc 1958;53:457-481.
8. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-202.
9. Mood MA. Introduction to the theory of statistics. New York: McGraw; 1950. p 398-406.
10. SPSS Inc. SPSS 6.1. Chicago: SPSS Inc. 1994.
11. Li WK, Lane JM, Rosen G, et al. Pelvic Ewing's sarcoma. J Bone Joint Surg 1983;65A:738-747.
12. Evans RG, Nesbit ME, Gehan EA, et al. Multimodal therapy for the management of localized Ewing's sarcoma and sacral bones: a report from the Second Intergroup study. J Clin Oncol 1991;9: 1173-1180.
13. Scully SP, Temple HT, O'Keefe RJ, et al. Role of surgical resection in pelvic Ewing's sarcoma. J Clin Oncol 1995;13:2336-2341.
14. Evans RG, Nesbit ME, Askin F, et al. Local recurrence rate and sites of metastases and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. Int J Radiat Oncol Biol Phys 1985;11:129-136.
15. Marcus RB, Million RR. The effect of primary tumor size on the prognosis of Ewing's sarcoma. Int J Radiat Oncol Biol Phys 1984; 10(Suppl 2):88.
16. Oberlin O, Habrand JL, Zucker JM, et al. No benefit of ifosfamide in Ewing's sarcoma: a non randomized study of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1407-1412.
17. Bacci G, Toni A, Avella M, et al. Long term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989;63:1477-1486.